- OCX Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
- ETFs
- Insider
- Institutional
- Shorts
-
10-K/A Filing
OncoCyte (OCX) 10-K/A2018 FY Annual report (amended)
Filed: 30 Apr 19, 4:17pm
Exhibit 31
CERTIFICATIONS
I, William Annett, certify that:
1. I have reviewed this annual report on Form 10-K/A ofOncoCyte Corporation;
2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
Date: April 30, 2019
/s/ William Annett | |
William Annett | |
Chief Executive Officer |
Exhibit 31
CERTIFICATIONS
I, Mitchell Levine, certify that:
1. I have reviewed this annual report on Form 10-K/A ofOncoCyte Corporation;
2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
Date: April 30, 2019
/s/ Mitchell Levine | |
Mitchell Levine | |
Chief Financial Officer |